Biológiai terápia szisztémás alkalmazása a szemészetben

Fruzsina Benyó, Alexandra Farkas, Hajnalka Horváth, Zoltán Zsolt Nagy, Zsuzsanna Szepessy
2019 Orvosi Hetilap  
Abstract: We present herewith cases of non-infectious uveitis with biological treatment where the ocular complaints were the initial symptoms indicating a multi-organ autoimmune disease. The first case was a patient with panuveitis and Vogt–Koyanagi–Harada disease, the second case was also a panuveitic patient with sarcoidosis and the third case was a patient with intermediate uveitis and inflammatory bowel disease. In all cases, emerging new, biological therapy (adalimumab) was necessary to
more » ... was necessary to achieve permanent inactive period of uveitis and the autoimmune disease. Introducing systemic biological treatment (adalimumab) in ophthalmology is crucial in the therapy of immune-mediated, non-infectious uveitis in order to preserve visual acuity. Orv Hetil. 2019; 160(44): 1744–1750.
doi:10.1556/650.2019.31552 fatcat:itgoc2r2aresvjtsmmawfg3wra